2019冠状病毒病（COVID-19）医护人员何时应重返工作岗位？对新冠病毒检测呈阳性后的后续抗原检测结果的分析。
When Should Healthcare Workers With Coronavirus Disease 2019 (COVID-19) Return to Work? An Analysis of Follow-up Antigen Test Results After a Positive COVID Test.
作者信息
Baffoe-Bonnie Anthony, Swann Mandy C, Kim Hyun Sue
机构信息
Carilion Clinic Infection Prevention and Control, Roanoke, Virginia, USA.
Virginia Tech Carilion School of Medicine, Roanoke, Virginia, USA.
出版信息
Open Forum Infect Dis. 2023 Mar 3;10(3):ofad114. doi: 10.1093/ofid/ofad114. eCollection 2023 Mar.
Abstract
A high percentage of healthcare workers (HCWs) who had met the Centers for Disease Control and Prevention criteria for returning to work 5 days after symptom onset remained positive for their return-to-work COVID-19 antigen test, suggesting continued infectiousness. Boosted HCWs were more likely to be antigen positive on their return-to-work test compared to unvaccinated HCWs, which merits further research.
摘要
很大比例的医护人员在出现症状5天后达到了疾病控制与预防中心的复工标准，但他们复工时的新冠病毒抗原检测仍呈阳性，这表明他们仍具有传染性。与未接种疫苗的医护人员相比，接种了加强针的医护人员复工检测时抗原呈阳性的可能性更大，这值得进一步研究。
相似文献
1
When Should Healthcare Workers With Coronavirus Disease 2019 (COVID-19) Return to Work? An Analysis of Follow-up Antigen Test Results After a Positive COVID Test.2019冠状病毒病（COVID-19）医护人员何时应重返工作岗位？对新冠病毒检测呈阳性后的后续抗原检测结果的分析。
Open Forum Infect Dis. 2023 Mar 3;10(3):ofad114. doi: 10.1093/ofid/ofad114. eCollection 2023 Mar.
2
Risk of SARS-CoV-2 transmission upon return to work in RNA-positive healthcare workers.新冠病毒阳性医护人员返岗后传播 SARS-CoV-2 的风险。
J Hosp Infect. 2022 Jun;124:72-78. doi: 10.1016/j.jhin.2022.02.024. Epub 2022 Mar 12.
3
COVID-19 Knowledge/Practices, Mental Status, and Return-To-Work Concerns Among Healthcare Workers in Huangzhou District, Huanggang City, China.中国湖北省黄冈市黄州区医护人员对 COVID-19 的认知/实践、精神状态和返工顾虑。
Front Public Health. 2022 Jan 14;9:723118. doi: 10.3389/fpubh.2021.723118. eCollection 2021.
4
COVID-19 Vaccination Status Among Healthcare Workers and Its Effect on Disease Manifestations: A Study From Northeast India.印度东北部医护人员的新冠疫苗接种状况及其对疾病表现的影响：一项研究
Cureus. 2022 May 20;14(5):e25159. doi: 10.7759/cureus.25159. eCollection 2022 May.
5
An early return-to-work program for COVID-19 close contacts in healthcare during the Omicron wave in Japan.日本奥密克戎疫情期间医护人员新冠密切接触者的早期返工项目。
J Infect Chemother. 2023 Jan;29(1):102-104. doi: 10.1016/j.jiac.2022.09.004. Epub 2022 Sep 8.
6
Healthcare workers benefit from second dose of COVID-19 mRNA vaccine: Effects of partial and full vaccination on sick leave duration and symptoms.医护人员从第二剂新冠病毒mRNA疫苗中受益：部分接种和全程接种对病假时长及症状的影响
Public Health Pract (Oxf). 2022 Jun;3:100247. doi: 10.1016/j.puhip.2022.100247. Epub 2022 Mar 29.
7
Return to Work, Demographic Predictors, and Symptomatic Analysis Among Healthcare Workers Presenting for COVID-19 Testing: A Retrospective Cohort From a United States Academic Occupational Medicine Clinic.参与新冠病毒检测的医护人员的复工情况、人口统计学预测因素及症状分析：来自美国一家学术性职业医学诊所的回顾性队列研究
Cureus. 2021 Nov 27;13(11):e19944. doi: 10.7759/cureus.19944. eCollection 2021 Nov.
8
Effectiveness of BNT162b2 mRNA Coronavirus Disease 2019 (COVID-19) Vaccine Against Acquisition of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Among Healthcare Workers in Long-Term Care Facilities: A Prospective Cohort Study.BNT162b2 mRNA 冠状病毒病 2019（COVID-19）疫苗在长期护理机构医护人员中预防严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）获得性感染的有效性：一项前瞻性队列研究。
Clin Infect Dis. 2022 Aug 24;75(1):e755-e763. doi: 10.1093/cid/ciab918.
9
COVID-19 symptoms, duration, and prevalence among healthcare workers in the New York metropolitan area.纽约都会区医护人员的 COVID-19 症状、持续时间和流行情况。
Infect Control Hosp Epidemiol. 2021 Aug;42(8):917-923. doi: 10.1017/ice.2020.1334. Epub 2020 Nov 20.
10
A nucleic acid amplification test-based strategy does not help inform return to work for healthcare workers with COVID-19.基于核酸扩增试验的策略并不能帮助有 COVID-19 的医护人员决定是否返回工作岗位。
Influenza Other Respir Viruses. 2022 Sep;16(5):851-853. doi: 10.1111/irv.13000. Epub 2022 May 26.
本文引用的文献
1
Duration of Shedding of Culturable Virus in SARS-CoV-2 Omicron (BA.1) Infection.新型冠状病毒奥密克戎（BA.1）感染中可培养病毒的脱落持续时间。
N Engl J Med. 2022 Jul 21;387(3):275-277. doi: 10.1056/NEJMc2202092. Epub 2022 Jun 29.
2
Viral Dynamics of Omicron and Delta Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants With Implications for Timing of Release from Isolation: A Longitudinal Cohort Study.奥密克戎和德尔塔变异株严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）的病毒动力学及其对隔离期结束时间的影响：一项纵向队列研究。
Clin Infect Dis. 2023 Feb 8;76(3):e227-e233. doi: 10.1093/cid/ciac510.
3
Comparison of Home Antigen Testing With RT-PCR and Viral Culture During the Course of SARS-CoV-2 Infection.在 SARS-CoV-2 感染过程中，家庭抗原检测与 RT-PCR 和病毒培养的比较。
JAMA Intern Med. 2022 Jul 1;182(7):701-709. doi: 10.1001/jamainternmed.2022.1827.
4
Utility of Follow-up Coronavirus Disease 2019 (COVID-19) Antigen Tests After Acute Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Healthcare Personnel.医护人员急性严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 感染后随访新冠病毒 2019（COVID-19）抗原检测的效用。
Clin Infect Dis. 2022 Aug 24;75(1):e347-e349. doi: 10.1093/cid/ciac235.
5
The Usefulness of Antigen Testing in Predicting Contagiousness in COVID-19.抗原检测在预测 COVID-19 传染性方面的作用。
Microbiol Spectr. 2022 Apr 27;10(2):e0196221. doi: 10.1128/spectrum.01962-21. Epub 2022 Mar 29.
6
Antigen Test Positivity After COVID-19 Isolation - Yukon-Kuskokwim Delta Region, Alaska, January-February 2022.2022 年 1 月至 2 月，阿拉斯加育空-科尤库克三角洲地区 COVID-19 隔离后抗原检测阳性。
MMWR Morb Mortal Wkly Rep. 2022 Feb 25;71(8):293-298. doi: 10.15585/mmwr.mm7108a3.
7
BNT162b2 Vaccine Booster and Mortality Due to Covid-19.BNT162b2 疫苗加强针与新冠病毒导致的死亡率。
N Engl J Med. 2021 Dec 23;385(26):2413-2420. doi: 10.1056/NEJMoa2115624. Epub 2021 Dec 8.
8
Evaluation of a Rapid Antigen Test To Detect SARS-CoV-2 Infection and Identify Potentially Infectious Individuals.评估一种快速抗原检测以检测 SARS-CoV-2 感染并识别可能具有传染性的个体。
J Clin Microbiol. 2021 Aug 18;59(9):e0089621. doi: 10.1128/JCM.00896-21.
Zotero 插件